Yüklüyor......
Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL
Timed degradation of the cyclin-dependent kinase inhibitor p27(Kip1) by the E3 ubiquitin ligase F-box protein SKP2 is critical for T-cell progression into cell cycle, coordinating proliferation and differentiation processes. SKP2 expression is regulated by mitogenic stimuli and by Notch signaling, a...
Kaydedildi:
| Yayımlandı: | Leukemia |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group UK
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7192844/ https://ncbi.nlm.nih.gov/pubmed/31772299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-019-0653-z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|